Form 4 Grace Therapeutics, Inc For: 27 September
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Grace Therapeutics, Inc (GRCE)
Track today's live Grace Therapeutics, (GRCE) share price, performance and key data on this page with our current NASDAQ:GRCE stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Grace Therapeutics, share price on the NASDAQ exchange. Use the dropdown to switch exchange for the GRCE share price, head to our technical summary section, which provides analysis on Grace Therapeutics, share price buy/sell indicators using real-time data (or discuss the Grace Therapeutics, (GRCE) stock price today with other investors in the Grace Therapeutics, NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:GRCE share price (ISIN: US00439U1043) to enhance your trading decisions with our free investment tools and resources.
What Is the Grace Therapeutics, Inc Share Price Today?
The Grace Therapeutics, share price today is 2.0400.
What Is the Stock Symbol for Grace Therapeutics, Inc
The stock symbol (or 'ticker') for Grace Therapeutics, Inc is "GRCE."
What Stock Exchange Does Grace Therapeutics, Inc Trade On?
Grace Therapeutics, Inc is listed and trades on the NASDAQ stock exchange.
Is Grace Therapeutics, Inc a Good Stock to Buy?
Determining whether Grace Therapeutics, (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:GRCE share price (ISIN: US00439U1043) to enhance your trading decisions with our free investment tools and resources.
What Is the Grace Therapeutics, Inc Share Price Today?
The Grace Therapeutics, share price today is 2.0400.
What Is the Stock Symbol for Grace Therapeutics, Inc
The stock symbol (or 'ticker') for Grace Therapeutics, Inc is "GRCE."
What Stock Exchange Does Grace Therapeutics, Inc Trade On?
Grace Therapeutics, Inc is listed and trades on the NASDAQ stock exchange.
Is Grace Therapeutics, Inc a Good Stock to Buy?
Determining whether Grace Therapeutics, (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.9800
2.1300
52 wk Range
1.7900
5.1800
GRCE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.98002.1300
52 wk Range
1.79005.1800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GRCE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
5.8549
Upside
+187.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Form 4 Grace Therapeutics, Inc For: 23 September- Investing.com
- Form 4 Grace Therapeutics, Inc For: 27 September
- Investing.com
- Form 4 Grace Therapeutics, Inc For: 23 September
- Investing.com
Form 4 Grace Therapeutics, Inc For: 22 September- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.8549
(+187.00% Upside)
Earnings
Latest Release
13/08/2026
EPS / Forecast
-0.91 / --
Revenue / Forecast
-- / --
Compare GRCE to Peers and Sector
Metrics to compare | GRCE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRCEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | 4.1x | −0.3x | |
PEG Ratio | 0.04 | 0.00 | 0.00 | |
Price/Book | 0.9x | 1.5x | 2.6x | |
Price / LTM Sales | - | 2.1x | 3.0x | |
Upside (Analyst Target) | 172.3% | 80.4% | 56.4% | |
Fair Value Upside | Unlock | 14.5% | 7.2% | Unlock |
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company’s lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-forming bupivacaine spray for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Grace Therapeutics, (NASDAQ: GRCE) Share Price Today?
The Grace Therapeutics, stock price today is 2.0400 USD.
What Stock Exchange Does Grace Therapeutics, (GRCE) Trade On?
Grace Therapeutics, is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Grace Therapeutics,?
The stock symbol (also called a 'ticker') for Grace Therapeutics, is "GRCE."
What Is the Current Grace Therapeutics, Market Capitalisation?
As of today, Grace Therapeutics, (NASDAQ: GRCE) market cap is 42.8100M USD.
What Is Grace Therapeutics,'s (GRCE) Earnings Per Share (TTM)?
The Grace Therapeutics, EPS is currently -1.2003 (Trailing Twelve Months).
Is GRCE a Buy or Sell From a Technical Analyst Perspective?
Based on today's Grace Therapeutics, moving averages and other technical indicators, the daily buy/sell signal for GRCE stock is Strong Sell.
How Many Times Has Grace Therapeutics, Stock Split?
Grace Therapeutics, has split 3 times. (See the GRCE stock split history page for full effective split date and price information.)
How Many Employees Does Grace Therapeutics, Have?
Grace Therapeutics, has 5 employees, based on their latest Companies House report.
What is the current trading status of Grace Therapeutics, (NASDAQ: GRCE)?
As of 01/10/2026, Grace Therapeutics, (GRCE) is trading at a share price of 2.0400 USD, with a previous close of 2.1500 USD. The stock has fluctuated within a day range of 1.9800 USD to 2.1300 USD, while its 52-week range spans from 1.7900 USD to 5.1800 USD.
What Is Grace Therapeutics, (GRCE) Price Target According to Analysts?
The average 12-month price target for Grace Therapeutics, is 5.8549 USD, with a high estimate of 7.8158338 USD and a low estimate of 3.89387984 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +187.00% Upside potential.
What Is the GRCE Premarket Price?
GRCE's last pre-market stock price is 2.1400 USD. The pre-market share volume is 70.0000, and the stock has decreased by -0.0100, or -0.4700%.
What Is the GRCE After Hours Price?
GRCE's last after hours stock price is 2.0700 USD, the stock has decreased by 0.0300, or 1.4700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.